| |
| |
|
| Insider
Information: |
Daniel Thomas O |
| Relationship: |
Director |
| City: |
Summit |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
171,350 |
|
|
Indirect Shares
|
41,295 |
|
|
| Direct
Value |
$5,502,647 |
|
|
|
Indirect Value
|
$374,558 |
|
|
| Total
Shares |
212,645 |
|
|
| Total
Value |
$5,877,205 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Celgene Corp |
CELG |
see remarks |
2015-12-23 |
49,972 |
2015-12-23 |
3,200 |
Premium* |
|
|
Larimar Therapeutics Inc |
LRMR |
Director |
2018-01-03 |
19,452 |
2017-02-13 |
0 |
Premium* |
|
|
Dianthus Therapeutics Ord Shs |
DNTH |
Director |
2018-06-25 |
101,926 |
2018-06-25 |
0 |
Premium* |
|
|
Gossamer Bio Inc |
GOSS |
Director |
2019-02-12 |
0 |
2019-02-12 |
38,095 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GOSS |
Gossamer Bio Inc |
Director |
– • – |
2019-02-12 |
4 |
A |
$0.00 |
$0 |
I/I |
38,095 |
38,095 |
0 |
- |
|
| DNTH |
Dianthus Therapeutics Ord... |
Director |
– • – |
2018-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
24,527 |
101,926 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Director |
– • – |
2018-01-03 |
4 |
A |
$5.18 |
$44,999 |
D/D |
8,687 |
19,452 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Director |
– • – |
2017-02-13 |
4 |
A |
$4.18 |
$44,998 |
D/D |
10,765 |
10,765 |
0 |
- |
|
| CELG |
Celgene Corp |
see remarks |
• – – |
2015-12-23 |
5 |
GD |
$0.00 |
$0 |
D/D |
15,793 |
49,972 |
0 |
- |
|
| CELG |
Celgene Corp |
see remarks |
• – – |
2015-12-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
69,678 |
0 |
- |
|
| CELG |
Celgene Corp |
see remarks |
• – – |
2015-12-17 |
4 |
D |
$112.17 |
$438,921 |
D/D |
(3,913) |
65,765 |
0 |
- |
|
| CELG |
Celgene Corp |
see remarks |
• – – |
2015-08-10 |
4 |
AS |
$130.82 |
$3,346,114 |
D/D |
(25,578) |
62,178 |
0 |
- |
|
| CELG |
Celgene Corp |
see remarks |
• – – |
2015-08-10 |
4 |
OE |
$29.75 |
$885,275 |
D/D |
25,578 |
87,756 |
0 |
- |
|
| CELG |
Celgene Corp |
see remarks |
• – – |
2015-07-28 |
4 |
AS |
$133.96 |
$3,981,291 |
D/D |
(29,720) |
55,532 |
0 |
- |
|
| CELG |
Celgene Corp |
see remarks |
• – – |
2015-07-28 |
4 |
OE |
$25.77 |
$1,082,760 |
D/D |
36,366 |
62,178 |
0 |
- |
|
| CELG |
Celgene Corp |
see remarks |
• – – |
2015-07-13 |
4 |
AS |
$120.78 |
$3,642,242 |
D/D |
(30,156) |
55,532 |
0 |
- |
|
| CELG |
Celgene Corp |
see remarks |
• – – |
2015-07-13 |
4 |
OE |
$25.77 |
$876,594 |
D/D |
30,156 |
85,688 |
0 |
- |
|
| CELG |
Celgene Corp |
see remarks |
• – – |
2015-04-30 |
4 |
D |
$108.06 |
$631,503 |
D/D |
(5,844) |
55,532 |
0 |
- |
|
| CELG |
Celgene Corp |
see remarks |
• – – |
2015-04-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,200 |
61,376 |
0 |
- |
|
| CELG |
Celgene Corp |
see remarks |
• – – |
2015-03-01 |
4 |
D |
$121.53 |
$528,412 |
D/D |
(4,348) |
50,176 |
0 |
- |
|
| CELG |
Celgene Corp |
see remarks |
• – – |
2015-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,334 |
54,524 |
0 |
- |
|
| CELG |
Celgene Corp |
see remarks |
• – – |
2015-02-06 |
4 |
D |
$118.75 |
$983,013 |
D/D |
(8,278) |
46,190 |
0 |
- |
|
| CELG |
Celgene Corp |
see remarks |
• – – |
2015-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
15,559 |
54,468 |
0 |
- |
|
| CELG |
Celgene Corp |
see remarks |
• – – |
2014-12-26 |
5 |
GD |
$0.00 |
$0 |
D/D |
6,491 |
38,909 |
0 |
- |
|
| CELG |
Celgene Corp |
see remarks |
• – – |
2014-12-15 |
4 |
AS |
$115.06 |
$3,451,872 |
D/D |
(30,000) |
45,400 |
0 |
- |
|
| CELG |
Celgene Corp |
see remarks |
• – – |
2014-12-15 |
4 |
OE |
$29.75 |
$892,500 |
D/D |
30,000 |
75,400 |
0 |
- |
|
| CELG |
Celgene Corp |
see remarks |
• – – |
2014-11-24 |
4 |
AS |
$110.27 |
$3,729,111 |
D/D |
(33,818) |
45,400 |
0 |
- |
|
| CELG |
Celgene Corp |
see remarks |
• – – |
2014-11-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,818 |
79,218 |
0 |
- |
|
| CELG |
Celgene Corp |
see remarks |
• – – |
2014-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
7,594 |
26,662 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
